Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2024

23-11-2023 | Breast Cancer | ASO Author Reflections

ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients

Authors: Charles Shelton, MD, Sarah M. Nielsen, MS

Published in: Annals of Surgical Oncology | Issue 2/2024

Login to get access

Excerpt

The benefits associated with guiding clinical management using germline genetic testing (GGT) contributed to the American Society of Breast Surgeons recommending universal testing for all breast cancer patients.1 Still, there are few reports of the real-world clinical utility of universal GGT for breast cancer. Patients with breast cancer living in rural communities face a number of barriers to cancer care, with higher mortality rates compared with those living in metropolitan areas. Whether universal GGT could be implemented in a rural breast cancer practice has not been studied. …
Literature
1.
Manahan ER, Kuerer HM, Sebastian M, et al. Consensus guidelines on genetic` testing for hereditary breast cancer from the American society of breast surgeons. Ann Surg Oncol. 2019;26(10):3025–31.CrossRefPubMedPubMedCentral
2.
3.
Kurian AW, Ward KC, Abrahamse P, et al. Association of germline genetic testing results with locoregional and systemic therapy in patients with breast cancer. JAMA Oncol. 2020;6(4):e196400.CrossRefPubMedPubMedCentral
Metadata
Title
ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients
Authors
Charles Shelton, MD
Sarah M. Nielsen, MS
Publication date
23-11-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14510-3

Other articles of this Issue 2/2024

Annals of Surgical Oncology 2/2024 Go to the issue

Breast Oncology

Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy

Endocrine Tumors

Medullary Thyroid Carcinoma: Why are One in Four Patients Treated Out of Concordance from the ATA Guidelines?

Gastrointestinal Oncology

Neoadjuvant Chemotherapy Improves Oncological Outcomes and Long-Term Survival Among Elderly Patients with Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis

ASO Author Reflections

ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers

ASO Author Reflections

ASO Author Reflections: International Classification of Diseases Codes for Social Determinants of Health: Still Not Ready for Prime Time

ASO Visual Abstract

ASO Visual Abstract: Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer